Page 70 - Michael Erman News Today

Most adults were already eligible for the additional shots, but fewer than 18% had received one, according to CDC data. But many public health officials felt the previous eligibility requirements were too complicated.

Most adults were already eligible for the additional shots, but fewer than 18% had received one, according to CDC data. But many public health officials felt the previous eligibility requirements were too complicated.

Most adults were already eligible for the additional shots, but fewer than 18% had received one, according to CDC data. But many public health officials felt the previous eligibility requirements were too complicated.

Most adults were already eligible for the additional shots, but fewer than 18% had received one, according to CDC data. But many public health officials felt the previous eligibility requirements were too complicated.

Most adults were already eligible for the additional shots, but fewer than 18% had received one, according to CDC data. But many public health officials felt the previous eligibility requirements were too complicated.

Nov 19 (Reuters) - U.S. regulators expanded eligibility for booster shots of COVID-19 vaccines to all adults on Friday, allowing millions more Americans to get additional protection against the virus amid a recent rise in infections. The director of the Centers for Disease Control and Prevention, Rochelle Walensky, signed off...

(Reuters) - U.S. regulators expanded eligibility for booster shots of COVID-19 vaccines to all adults on Frida...

HEALTH-CORONAVIRUS/PFIZER-TREATMENTS (UPDATE 5, PIX, GRAPHIC):UPDATE 5-Pfizer says its antiviral pill slashes risk of severe COVID-19 by 89%

CDC Director Rochelle Walensky must sign off on recommendations before the United States can begin administering the vaccine to children in the age group. The U.S. Food and Drug Administration granted emergency use authorization of the vaccine in 5-11 year olds on Friday.

CDC Director Rochelle Walensky must sign off on recommendations before the United States can begin administering the vaccine to children in the age group. The U.S. Food and Drug Administration granted emergency use authorization of the vaccine in 5-11 year olds on Friday.